Company / Current Assets
Monte Rosa Therapeutics, Inc. Current Assets History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$377.4M
FY2024
5-year range
$43.6M / $377.4M
FY2020-FY2024
Trend
+59.8%
vs FY2023
Sector context
#140 of 213
Health Care
What the data says
At $377M, Monte Rosa Therapeutics, Inc.'s current assets ranks #140 of 213 in the Health Care sector. Current Assets returned to growth in FY2024 after 2 years of decline, reaching $377M.
Based on SEC 10-K filings.
$377M in FY2024 with a 3-year CAGR of +2.7%.
Improved from $276M to $377M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +2.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#140 of 213 in Health CareTop 66% of 213This company $377.4M Sector average $2.5B
▼
-85.0% below sector average
Key checks
Key Insights
- 3-year CAGR of +2.7%, indicating consistent growth.
- In FY2024, current assets increased 59.8% year-over-year.
- Ranks #140 out of 213 companies in the Health Care sector.
- Lowest current assets in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $377.4M | +59.8% |
| FY2023 | $236.2M | -14.4% |
| FY2022 | $275.9M | -20.9% |
| FY2021 | $348.7M | +699.9% |
| FY2020 | $43.6M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026